// App-Quantinova.ai

1126 : Hepatitis B reactivation during DAA therapy for Hepatitis C ‐ does it affect clinical outcomes?

Researchers

Presenter

  • Ruth Byrne

Principal Investigators

  • Michelle Spaan

  • Mary Cannon

  • Geoffrey M. Dusheiko

  • Ivana Carey

  • Kosh Agarwal

Medical Centers

  • King's College Hospital, Institute of Liver Studies, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Hepatitis B

  • Hepatitis C

  • Cirrhosis

Biomarkers

  • Alanine transaminase

  • Hepatitis B surface antigen

  • Serum hepatitis B virus DNA

Drug/Treatment

  • Lamivudine

  • Sofosbuvir

  • Interferon

  • Ribavirin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved